InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
11
T+90 hit rate
38%
T+90 mean return
-5.6%
Across 24 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Sullivan Timothy Eugene, Chief Financial Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 37 filings have been logged. Breakdown: 0 buy · 11 sells. Total volume traded: €6.4m. Activity tracked since 8 June 2021. The latest transaction was filed on 29 January 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations37 total
140,945 sharesCommon StockSEC:0001193125-26-224615:0
140,945 sharesCommon StockSEC:0001193125-26-224615
▼
546 shares@ US$29.52360.2% of flowCommon StockSEC:0001127602-25-002385:0
▼
3,088 shares@ US$30.42551.2% of flowCommon StockSEC:0001127602-25-001843:0
▼
1,730 shares@ US$29.95820.7% of flowCommon StockSEC:0001127602-25-001627:0
45,929 shares0Common StockSEC:0001127602-25-001627:1
▼
2,170 shares@ US$28.70210.8% of flowCommon StockSEC:0001127602-25-001202:0
◇
1,042 shares@ US$14.950.2% of flowCommon StockSEC:0001127602-25-000388:0
14,164 shares0Common StockSEC:0000950170-24-046178:0
◇
4,000 shares@ US$10.030.5% of flowCommon StockSEC:0001127602-24-011814:0
◇
6,000 shares@ US$10.030.7% of flowCommon StockSEC:0001127602-24-008499:0
▼
1,431 shares@ US$67.76691.2% of flowCommon StockSEC:0001127602-24-004721:0
▼
906 shares@ US$64.13820.7% of flowCommon StockSEC:0001127602-24-002749:0
▼
3,551 shares@ US$64.9962.8% of flowCommon StockSEC:0001127602-24-001956:0
23,748 shares0Common StockSEC:0001127602-24-001433:0
◇
14,158 shares@ US$10.031.7% of flowCommon StockSEC:0001127602-23-028592:0
◇
6,779 shares@ US$10.030.8% of flowCommon StockSEC:0001127602-23-020394:0
◇
69,779 shares@ US$10.038.7% of flowCommon StockSEC:0001127602-23-018065:0
▼
1,600 shares@ US$90.60441.8% of flowCommon StockSEC:0001127602-23-018065:1
30,609 shares@ US$87.788633.5% of flowCommon StockSEC:0001127602-23-018065:2
▼
7,064 shares@ US$88.36497.8% of flowCommon StockSEC:0001127602-23-018065:3
30,506 shares@ US$89.825934.1% of flowCommon StockSEC:0001127602-23-018065:4
20,000 shares0Common StockSEC:0000899243-23-012086:0
36,232 shares0Common StockSEC:0000899243-23-011479:0
11,683 shares0Common StockSEC:0000899243-23-005783:0
25 of 37 declarations
About Sullivan Timothy Eugene
Timothy Eugene Sullivan is the Chief Financial Officer at Apellis Pharmaceuticals, Inc. He is responsible for financial management and strategy for the company. Sullivan plays a key role in optimizing financial processes and implementing strategies aimed at improving Apellis' financial performance.
